⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439164 | 1.00 | — | — | |
| SCHEMBL988689 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL25318862 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL25235322 | 0.96 | — | — | |
| SCHEMBL4014867 | 0.79 | — | — | |
| SCHEMBL2382246 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL9847517 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL31268132 | 0.75 | — | — | |
| SCHEMBL30069079 | 0.72 | — | — | |
| SCHEMBL19343233 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7034176-B2 | Aminopropylphosphinic acids | ASTRAZENECA AB (SE) | 2006-04-25 | — | — | US | claimed |
| US-20050137414-A1 | New aminopropylphosphinic acids | ELEBRING THOMAS (SE) | 2005-06-23 | — | — | US | claimed |
| US-20030220303-A1 | New aminopropylphosphinic acids | ELEBRING THOMAS (SE) | 2003-11-27 | — | — | US | claimed |
| US-6596711-B1 | GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux | ASTRAZENECA AB (SE) | 2003-07-22 | — | — | US | claimed |
| CN-1413104-A | New (aminopropyl) methylphosphinic acids | ASTRAZENECA AB (SE) | 2003-04-23 | — | — | CN | claimed |
| CN-1409716-A | New amino propylphosphinic acid | ASTRAZENECA AB (SE) | 2003-04-09 | — | — | CN | claimed |
| US-20020156053-A1 | New aminopropylphosphinic acids | GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT | 2002-10-24 | — | — | US | claimed |
| CN-117886824-B | 2, 3-Dihydropyrimido [4,5-d ] pyrimidine-4 (1H) -ketone derivative, preparation method and application thereof | 四川大学华西医院 | 2026-05-15 | — | — | CN | disclosed |
| EP-4688161-A1 | IL4I1 INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme LLC (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4658662-A1 | MACROCYCLIC AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | Yuhan Corporation (KR) | 2025-12-10 | — | — | EP | disclosed |
| EP-4655304-A1 | MACROCYCLIC AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | Yuhan Corporation (KR) | 2025-12-03 | — | — | EP | disclosed |
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
| EP-4617273-A1 | FUSED TRICYCLIC PARP1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Haihe Biopharma Co., Ltd. (CN) | 2025-09-17 | — | — | EP | disclosed |
| CN-1413104-A | New (aminopropyl) methylphosphinic acids | ASTRAZENECA AB (SE) | 2003-04-23 | — | — | CN | disclosed |
| CN-1409716-A | New amino propylphosphinic acid | ASTRAZENECA AB (SE) | 2003-04-09 | — | — | CN | disclosed |
| US-20020156053-A1 | New aminopropylphosphinic acids | GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT | 2002-10-24 | — | — | US | disclosed |
| EP-1239843-A1 | NEW (AMINOPROPYL)METHYLPHOSPHINIC ACIDS | AstraZeneca AB (SE) | 2002-09-18 | — | — | EP | disclosed |
| EP-1240172-A1 | NEW AMINOPROPYLPHOSPHINIC ACIDS | AstraZeneca AB (SE) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001042252-A1 | NEW AMINOPROPYLPHOSPHINIC ACIDS | ASTRAZENECA AB (SE) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001041743-A1 | NEW (AMINOPROPYL)METHYLPHOSPHINIC ACIDS | ASTRAZENECA AB (SE) | 2001-06-14 | — | — | WO | disclosed |